COP vs IRD
ConocoPhillips (COP) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. IRD currently screens at market cap $35.7M.
Not investment advice. Open the COP and IRD stock pages for the full models.
Not investment advice.